Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03191058 · ClinicalTrials.gov registry record · NA
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 239
- Enrollment target
NCT03191058 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 239 participants.
The verdict
NCT03191058, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 239 participants
- Enrollment target
Study Summary
This trial aims to assess the efficacy and tolerability of Magnetic Seizure Therapy (MST) as an alternative to electroconvulsive therapy (ECT) for depression. Even with multiple medication trials, 30 - 40% of patients will experience a pharmacologically resistant form of illness. The ineffectiveness of current treatments for major depressive disorder (MDD) coupled with the economic burden associated with the disorder engenders a need for novel therapeutic interventions that can provide greater response and remission rates.
Interventions
- DEVICE Electroconvulsive Therapy
- DEVICE Magnetic Seizure Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2018-06-26 |
| Est. Completion | 2024-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03191058
The ClinicalTrials.gov registry entry for NCT03191058 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electroconvulsive Therapy is the first listed.
NCT03191058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03191058 about?
NCT03191058 is a clinical study titled "Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression". This trial aims to assess the efficacy and tolerability of Magnetic Seizure Therapy (MST) as an alternative to electroconvulsive therapy (ECT) for depression. Even with multiple medication trials, 30 - 40% of patients will experience a pharmacologically resistant form of illness. The ineffectiveness...
What is the current status of trial NCT03191058?
This trial is currently completed. It is a NA study. The enrollment target is 239 participants. The study started on 2018-06-26. Estimated completion is 2024-11-22.
What interventions are being tested in trial NCT03191058?
The interventions under investigation include: Electroconvulsive Therapy (DEVICE), Magnetic Seizure Therapy (DEVICE).
Who is sponsoring clinical trial NCT03191058?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.